Immunomedics (IMMU) EBITDA US GAAP (year values)

FY2014 FY2015 FY2016 FY2017 FY2018   LTM ? CAGR 5 years ?
EBITDA, bln rub ? -34.8 -45.3 -57.9 -146.8 -249.1   -261.2  
Changes by years, y/y, % +214% +30% +28% +154% +70%     +86.4%

Immunomedics. EBITDA US GAAP, bln rub

Immunomedics. EBITDA US GAAP, changes, %

Immunomedics. EBITDA US GAAP, sum by quarters, bln rub

Immunomedics (IMMU) EBITDA US GAAP (quarter values)

FY2017Q4 FY2018Q1 FY2018Q2 FY2020Q1 FY2020Q2   LTM ?
EBITDA, bln rub ? -1.82 -24.3 -107.1 -78.5 -51.3   -261.2
Changes by years, y/y, % -92% -58% +108%    
Changes by quarters, q/q, % -98% +1 234% +340% -27% -35%    

Immunomedics. EBITDA US GAAP, bln rub

Immunomedics. EBITDA US GAAP, changes, y/y, %

Immunomedics. EBITDA US GAAP, changes, q/q, %